Myriad Genetics, Inc. (MYGN)
4.29
-0.09
(-2.05%)
USD |
NASDAQ |
Feb 20, 16:00
4.29
0.00 (0.00%)
After-Hours: 20:00
Myriad Genetics Profit Margin (Quarterly) : -13.32% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ICU Medical, Inc. | -2.91% |
| Intuitive Surgical, Inc. | 27.89% |
| Insulet Corp. | 12.96% |
| West Pharmaceutical Services, Inc. | 16.39% |
| Celldex Therapeutics, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -69.09% |
| Return on Assets | -44.30% |
| Return on Invested Capital | -54.03% |
| Gross Profit Margin (Quarterly) | 66.07% |
| Operating Margin (Quarterly) | -11.33% |
| Return on Net Operating Assets | -52.60% |